Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good
India | July 11, 2020 20:38 ISTThe Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".